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The efficient therapy in ocular diseases is limited by the physiological barriers and defensive 
mechanisms of the eye. To reach the proper therapeutic effect, development of novel 
ophthalmic formulations is necessary with increased drug permeation and retention time on 
the surface of the eye.  
Cyclodextrin (CD) derivatives are commonly used as additives in different pharmaceutical 
products. CDs can form water-soluble inclusion complex with lipophilic active ingredients, 
thus the increased penetration and improved stability of the dissolved drug are expected [1]. 
In this work eye drop formulations were developed with increased efficacy and stability. All 
formulations were set to the required parameters, which meet the physiological parameters 
of eye. Firstly, cyclodextrin derivatives were used to enhance the efficacy of the anti-
inflammatory prednisolone by formation of water-soluble inclusion complex. To increase the 
retention time of this formulation, mucadhesive antimicrobial polymer was applied. The drug-
cyclodextrin complex formation, the diffusion of prednisolone, surface tension, viscosity, 
mucoadhesivity and the antimicrobial stability of the eye drops were investigated by different 
methods [2]. The cytotoxicity and drug permeation were studied on human corneal epithelial 
cell lines. In the second main part, the stability of antibiotic, rifampicin containing eyedrops 
was enhanced by cyclodextrin inclusion complex and freeze-drying method. The stability of 
the rifampicin-cyclodextrin complexes and freeze-dried samples was investigated at different 
circumstances and time periods by HPLC. The residual moisture and reconstitution time were 
also studied. 
According to the results, this work can be an innovative approach to develop ophthalmic 
formulations with increased efficacy and stability. 
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